5.72 USD
+0.32 (+5.93%)
AEZS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of AEZS have multiple concerns. AEZS is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year AEZS has reported negative net income.
- AEZS had a negative operating cash flow in the past year.
- AEZS had negative earnings in each of the past 5 years.
- AEZS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- AEZS has a Return On Assets (-56.80%) which is in line with its industry peers.
- AEZS's Return On Equity of -139.22% is on the low side compared to the rest of the industry. AEZS is outperformed by 62.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -56.8% | ||
| ROE | -139.22% | ||
| ROIC | N/A |
ROA(3y)-31.91%
ROA(5y)-27.9%
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AEZS's Gross Margin of 90.69% is amongst the best of the industry. AEZS outperforms 93.18% of its industry peers.
- In the last couple of years the Gross Margin of AEZS has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for AEZS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 90.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.35%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
- AEZS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AEZS has been reduced compared to 1 year ago.
- The debt/assets ratio for AEZS is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -16.76, we must say that AEZS is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of AEZS (-16.76) is worse than 85.49% of its industry peers.
- A Debt/Equity ratio of 0.01 indicates that AEZS is not too dependend on debt financing.
- AEZS has a Debt to Equity ratio (0.01) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.76 |
ROIC/WACCN/A
WACC10.12%
2.3 Liquidity
- A Current Ratio of 5.94 indicates that AEZS has no problem at all paying its short term obligations.
- With a Current ratio value of 5.94, AEZS perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
- A Quick Ratio of 5.93 indicates that AEZS has no problem at all paying its short term obligations.
- With a Quick ratio value of 5.93, AEZS perfoms like the industry average, outperforming 59.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.94 | ||
| Quick Ratio | 5.93 |
3. Growth
3.1 Past
- The earnings per share for AEZS have decreased strongly by -274.15% in the last year.
- Looking at the last year, AEZS shows a very negative growth in Revenue. The Revenue has decreased by -62.06% in the last year.
- Measured over the past years, AEZS shows a very negative growth in Revenue. The Revenue has been decreasing by -30.07% on average per year.
EPS 1Y (TTM)-274.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-438.43%
Revenue 1Y (TTM)-62.06%
Revenue growth 3Y6.73%
Revenue growth 5Y-30.07%
Sales Q2Q%-99.81%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.27%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AEZS. In the last year negative earnings were reported.
- Also next year AEZS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- AEZS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AETERNA ZENTARIS INC / AEZS FAQ
What is the fundamental rating for AEZS stock?
ChartMill assigns a fundamental rating of 1 / 10 to AEZS.
Can you provide the valuation status for AETERNA ZENTARIS INC?
ChartMill assigns a valuation rating of 0 / 10 to AETERNA ZENTARIS INC (AEZS). This can be considered as Overvalued.
Can you provide the profitability details for AETERNA ZENTARIS INC?
AETERNA ZENTARIS INC (AEZS) has a profitability rating of 1 / 10.